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Background: Patients with coronary artery disease and myocardial ischemia as manifested by myocardial perfusion abnormalities are often 
treated with revascularization that is not fully supported by outcomes data. The COURAGE trial has challenged this practice by suggesting equivalent 
outcomes in patients treated medically vs. revascularization. 
Methods: We studied 2307 consecutive patients from 9/1993 to 6/2009 with significant coronary disease and two serial SPECT perfusion scans 
who were treated medically (1477), PCI (399) or CABG (199) from the Duke Nuclear Cardiology Databank and the Duke Databank for Cardiovascular 
Disease. Extent and severity of perfusion abnormalities were described by the Sum Stress Score (SSS). The median time between the two consecutive 
SPECT scans was 523 days. 
Results: The 3 groups of patients were similar with respect to cardiac risk factors. Results of baseline and follow-up SPECT perfusion studies 
are shown below. Patients treated medically were more likely to have worsening perfusion abnormalities (35%) vs. PCI (22%) vs. CABG (24%) 
p<0.01. Over 60% of patients treated medically show no improvement or worsening of perfusion scores compared to 33% in patients treated with 
revascularization (p<0.01). 
Characteristic Total Med PCI CABG p-value
Age median (Q1,Q3) 62 (53,70) 62 (53,70) 63 (54,71) 61 (53,70) 0.50
Male % 67.1 65.9 68.5 71.4 0.21
Change in perfusion SSS 0 (-3,2) 0 (-2,2) -2 (-5,0) -3 (-6,0) <0.01
Worsening perfusion % 32.8 38.7 21.8 24.12 <0.01
Conclusion: These data suggest revascularization with PCI or CABG may improve SPECT perfusion scores compared to medical therapy. Further 
studies are needed to evaluate the impact of this imaging modality in guiding therapy in patients with coronary disease.
